Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies

Keyphrases

• Clinical Significance 100%
• Neutralizing Antibodies 100%
• SARS-CoV-2 Receptor Binding Domain 100%
• Monoclonal Antibody 50%
• Binding Site 50%
• Receptor-binding Domain 50%
• Protein Receptor 50%
• Antibody Response 50%
• Vaccine Development 50%
• Molecular Features 50%
• Therapeutic Development 50%
• Site Features 50%
• Host Receptor 50%
• Spike Protein 50%
• Viral Entry 50%
• Pandemic Virus 50%
• Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) 50%
• COVID-19 50%
• COVID-19 Pandemic 50%
• Virus SARS-CoV-2 50%
• ACE2 Receptor 50%
• COVID-19 Research 50%
• Antibodies to SARS-CoV-2 50%
• SARS-CoV-2 Neutralizing Antibody 50%
• Novel Pandemic 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Receptor 100%
• Neutralizing Antibody 100%
• SARS Coronavirus 100%
• Binding Site 14%
• Monoclonal Antibody 14%
• Vitronectin 14%
• Pandemic 14%